affordable glp-1 drugs Access to weight loss medication may be more than you think. The new Medicare GLP-1 Bridge Program may help eligible Medicare patients receive select GLP-1 medications for approximately $50 per new glp-1 GLP-1 drugs now

Although not contraindicated, clinicians should closely monitor thyroid function tests and adjust therapy as weight and metabolic status evolve under GLP-1RA treatment [65]

The prevention of diabetes is an urgent issue

Tongzhi Wu, Adelaide Medical School, The University of Adelaide, Adelaide, SA 5000, Australia

This clinical trial did not include patients with T2D, and the emerging data suggests that the weight-loss effects of tirzepatide are reduced in patients with diabetes, a difference also observed in trials with 2.4 mg of semaglutide 2

Available online at: (cited March 17, 2025)

Decision Support Tool: Features to Consider in Determining if a Clinical Trial is Phase II or Phase III